A New York federal jury on Tuesday, February 5th, ordered Merck & Co. to pay $285,000 in a lawsuit over the risks of its osteoporosis drug, Fosamax; the second loss for the company after several earlier trials.
The eight-person...
A New York Dangerous Drug Lawyer Warns that the FDA Cautions Use of Fosamax
Fosamax users may want to think twice about continuing its use, and speak to a New York dangerous...
FDA Confirms Link Between Biphosphonates And Thigh Fractures
(July 7, 2012)
Bone strengthening drugs (bisphosphonates), more commonly known as alendronate (Fosamax), ibandronate (Boniva), risedronate (Actonel), and zoledronic acid (Reclast), were first...